Conference Coverage

Psychiatric comorbidities add to migraineurs’ medical interventions


 

AT THE AAN 2014 ANNUAL MEETING

PHILADELPHIA – Patients who have migraines and comorbid psychiatric disorders visited the emergency department more, and received more brain imaging and narcotics, than patients who had only migraine.

The additional emergency visits and procedures – combined with significantly higher rates of hospital admissions and outpatient visits – run contrary to published recommendations, Dr. Mia Minen reported at the annual meeting of the American Academy of Neurology.

The imaging findings of her cross-sectional analysis are particularly troubling in light of current guidelines aimed at helping to minimize radiation exposure by avoiding head and brain imaging in patients with primary headache disorders, said Dr. Minen, a fellow at the Graham Headache Center, Boston.

"One of the AAN’s recommendations for the Choosing Wisely campaign was not to perform brain imaging for patients presenting to the ED with recurrence of their baseline primary headache disorder," she said. She added that the American College of Emergency Physicians has not found level A evidence supporting imaging in patients who present to the emergency department with headache, unless the headache is sudden and severe, or unless it’s accompanied by an abnormal neurological exam.

Her analysis looked at emergency treatment trends in a database of almost 3,000 headache patients seen over a 10-year period in a single hospital’s emergency department. The patients were a mean of 40 years old; most (80%) were women. About 2,000 had at least one psychiatric comorbidity; the most common psychiatric comorbidities were anxiety and depression.

Over the 10-year study period, migraine patients overall made an average of 11 ED visits, with 10 admissions and 26 outpatient visits. Those patients without a comorbid psychiatric diagnosis made significantly fewer visits in every category: 6 ED visits, 3 inpatient visits, and 11 outpatient visits.

Migraine patients with comorbidities presented a very different picture, Dr. Minen said. These patients had an average of 18 ED visits, 19 inpatient visits, and 45 outpatient visits over the study period.

Compared with migraineurs without psychiatric disorders, those with them were significantly more likely to undergo a CT of the head (relative risk, 1.4) and an MRI of the brain (RR, 1.5). They received narcotic treatment in the ED significantly more often as well.

"We need more studies to understand why this is the case," Dr. Minen said.

She added that the pharmacotherapy findings also were in contrast to recommendations in the AAN Choosing Wisely campaign.

"In 2013, one of the final recommendations was not to use opiates or butalbital for the treatment of migraine, except in rare circumstances."

Dr. Minen had no financial disclosures.

msullivan@frontlinemedcom.com

Recommended Reading

Naloxone autoinjector approved for caregiver use in treating opioid overdoses
MDedge Psychiatry
VIDEO: Practice pearls for treating opiate dependence
MDedge Psychiatry
CGRP-targeted migraine prevention drugs succeed in phase II
MDedge Psychiatry
FDA panel not convinced by opiate combination safety
MDedge Psychiatry
Many migraine patients quit meds by 12 months
MDedge Psychiatry
Physician education key to curbing opioid abuse
MDedge Psychiatry
AUDIO: CBT better for comorbid depression, anxiety in migraine
MDedge Psychiatry
Longer-term opioid use in workers’ comp cases highest in Louisiana
MDedge Psychiatry
Chronic migraine affects education, employment, and income
MDedge Psychiatry
AUDIO: Reduction in perceived stress triggers migraine
MDedge Psychiatry